- Home
- BATL vs EVOK Comparison
BATL vs EVOK Comparison
Compare BATL & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BATL | EVOK |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 18.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BATL | EVOK |
|---|---|---|
| Price | $1.16 | $10.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 76.2K | 46.1K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $183,422,000.00 | $14,424,652.00 |
| Revenue This Year | N/A | $57.38 |
| Revenue Next Year | N/A | $59.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.40 |
| 52 Week Low | $1.00 | $1.94 |
| 52 Week High | $3.67 | $10.94 |
Technical Indicators
Market Signals| Indicator | BATL | EVOK |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 84.82 |
| Support Level | $1.11 | $10.66 |
| Resistance Level | $1.15 | $10.75 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 50.00 | 96.43 |
Price Performance
Historical ComparisonAbout BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.